Insider Trading & Ownership - Design Therapeutics Inc. (DSGN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Design Therapeutics Inc.
Goto Prev, 0, 1, 2

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership(A)
2021-03-30
5:44 pm
N/A
N/A
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
SR ONE CAPITAL PARTNERS I LP
SR ONE CAPITAL MANAGEMENT LLC
10% Owner
0 $0 5,376,476
(Direct)
View
2021-03-25
Option Award
2021-03-29
6:31 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN Xu Stella
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:56 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN William Arsani
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:55 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN Schmid John P.
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:54 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN LAPPE RODNEY W
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:52 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
15,000 $0 15,000
(Direct)
View

Ownership
2021-03-25
9:17 pm
N/A
N/A
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
10% Owner
0 $0 5,376,476
(Direct)
View

Ownership
2021-03-25
9:15 pm
N/A
N/A
Design Therapeutics Inc. DSGN Xu Stella
Quan Venture Fund II L.P.
Director
10% Owner
0 $0 4,720,830
(Indirect)
View

Ownership
2021-03-25
9:15 pm
N/A
N/A
Design Therapeutics Inc. DSGN William Arsani
Director
0 $0 2,032,501
(Indirect)
View

Ownership
2021-03-25
9:14 pm
N/A
2030-12-06
Design Therapeutics Inc. DSGN Thacker Justin
Vice President, Finance
0 $0 92,024
(Direct)
View

Ownership
2021-03-25
9:12 pm
N/A
N/A
Design Therapeutics Inc. DSGN Star Irrevocable Trust #1 dated April 22 2019
10% Owner
0 $0 3,834,355
(Direct)
View

Ownership
2021-03-25
9:10 pm
N/A
N/A
Design Therapeutics Inc. DSGN Siffert Joao MD
President and CEO
0 $0 766,870
(Direct)
View

Ownership
2021-03-25
9:09 pm
N/A
N/A
Design Therapeutics Inc. DSGN Shah Pratik
Executive Chairperson
0 $0 104,923
(Indirect)
View

Ownership
2021-03-25
9:08 pm
N/A
N/A
Design Therapeutics Inc. DSGN Schmid John P.
Director
0 $0 30,674
(Direct)
View

Ownership
2021-03-25
9:07 pm
N/A
N/A
Design Therapeutics Inc. DSGN Light Irrevocable Trust #1 dated April 22 2019
10% Owner
0 $0 3,834,355
(Direct)
View

Ownership
2021-03-25
9:06 pm
N/A
N/A
Design Therapeutics Inc. DSGN LAPPE RODNEY W
Director
0 $0 92,024
(Direct)
View

Ownership
2021-03-25
9:02 pm
N/A
N/A
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
0 $0 5,376,476
(Indirect)
View

Ownership
2021-03-25
8:55 pm
N/A
N/A
Design Therapeutics Inc. DSGN Jeffries Sean
Chief Operating Officer
0 $0 807,233
(Direct)
View

Ownership
2021-03-25
8:51 pm
N/A
N/A
Design Therapeutics Inc. DSGN Ansari Aseem Z.
10% Owner
0 $0 7,668,711
(Direct)
View

Ownership
2021-03-25
5:11 pm
N/A
N/A
Design Therapeutics Inc. DSGN Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Cormorant Private Healthcare Fund III LP
10% Owner
0 $0 4,364,844
(Indirect)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2